You just read:

Braeburn Pharmaceuticals Announces FDA Approves Probuphine® (buprenorphine) Implant: The First Implant for Treatment of Opioid Dependence

News provided by

Braeburn Pharmaceuticals

May 26, 2016, 19:26 ET